Early improvement in positive rather than negative emotion predicts remission from depression after pharmacotherapy

European Neuropsychopharmacology

Volumn 21, Issue 3, 2011, Pages 241-247

  Geschwind, Nicole ^a   Nicolson, Nancy A ^a   Peeters, Frenk ^a   van Os, Jim ^a,c   Barge Schaapveld, Daniela ^b   Wichers, Marieke ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Affect; Depression; Early improvement; Experience sampling method; Prognosis; Treatment response

Indexed keywords

IMIPRAMINE; PLACEBO;

ADULT; ARTICLE; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; EMOTION; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; HUMANS; IMIPRAMINE; MALE; MIDDLE AGED; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SELF-ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 79251614010     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.11.004     Document Type: Article

References (30)

1. Bagby R.M., Ryder A.G., Schuller D.R., Marshall M.B. The Hamilton Depression Rating Scale: has the gold standard become a lead weight?. Am. J. Psychiatry 2004, 161:2163-2177.
2. Ballesteros J., Bobes J., Bulbena A., Luque A., Dal-Ré R., Ibarra N., Güemes I. Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton Depression Rating Scale (HAMD). J. Affect. Disord. 2007, 102:93-99.
3. Barge-Schaapveld D., Nicolson N.A. Effects of antidepressant treatment on the quality of daily life: an experience sampling study. J. Clin. Psychiatry 2002, 63:477-485.
4. Block J., Kremen A.M. IQ and ego-resiliency: Conceptual and empirical connections and separateness. J Pers Soc Psychol 1996, 70:349-361.
5. Cohn M.A., Fredrickson B.L., Brown S.L., Mikels J.A., Conway A.M. Happiness unpacked: positive emotions increase life satisfaction by building resilience. Emotion 2009, 9:361-368.
6. Csikszentmihalyi M., Larson R. Validity and reliability of the experience sampling method. J. Nerv. Ment. Dis. 1987, 175:526-536.
7. Delespaul P.A.E.G. Assessing Schizophrenia in Daily Life. The Experience Sampling Method 1995, Maastricht University Press, Maastricht.
8. Depue R.A., Luciana M., Arbisi P., Collins P., Leon A. Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality. J. Pers. Soc. Psychol. 1994, 67:485-498.
9. Dichter G.S., Tomarken A.J., Freid C.M., Addington S., Shelton R.C. Do venlafaxine XR and paroxetine equally influence negative and positive affect?. J. Affect. Disord. 2005, 85:333-339.
10. Fredrickson B.L., Tugade M.M., Waugh C.E., Larkin G.R. What good are positive emotions in crises? A prospective study of resilience and emotions following the terrorist attacks. J. Pers. Soc. Psychol. 2003, 84:365-376.
11. Geschwind N., Peeters F., Jacobs N., Delespaul P., Derom C., Thiery E., van Os J., Wichers M. Meeting risk with resilience: high daily life reward experience preserves mental health. Acta Psychiatr. Scand. 2010, 122:129-138.
12. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
13. Harmer C.J., de Bodinat C., Dawson G.R., Dourish C.T., Waldenmaier L., Adams S., Cowen P.J., Goodwin G.M. Agomelatine facilitates positive versus negative affective processing in healthy volunteer models. J. Psychopharmacol. 2010, 10.1177/0269881110376689.
14. Henkel V., Seemuller F., Obermeier M., Adli M., Bauer M., Mundt C., Brieger P., Laux G., Bender W., Heuser I., Zeiler J., Gaebel W., Mayr A., Moller H.J., Riedel M. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J. Affect. Disord. 2009, 115:439-449.
15. Karson C., Kleinman J., Berman K., Phelps B., Wise C., DeLisi L., Jeste D. An inverse correlation between spontaneous eye-blink rate and platelet monoamine oxidase activity. Br. J. Psychiatry 1983, 142:43-46.
16. McFarland B.R., Klein D.N. Emotional reactivity in depression: diminished responsiveness to anticipated reward but not to anticipated punishment or to nonreward or avoidance. Depress. Anxiety 2009, 26:117-122.
17. Nutt D., Demyttenaere K., Janka Z., Aarre T., Bourin M., Canonico P.L., Carrasco J.L., Stahl S. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J. Psychopharmacol. 2007, 21:461-471.
18. Papakostas G.I., Perlis R.H., Scalia M.J., Petersen T.J., Fava M. A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder. J. Clin. Psychopharmacol. 2006, 26:56-60.
19. Posternak M.A., Zimmerman M. Is there a delay in the antidepressant effect? A meta-analysis. J. Clin. Psychiatry 2005, 148-158.
20. Quitkin F.M., Rabkin J.G., Ross D., Stewart J.W. Identification of true drug response to antidepressants: use of pattern analysis. Arch. Gen. Psychiatry 1984, 41:782-786.
21. Stassen H.H., Angst J., Hell D., Schayfetter C., Szegedi A. Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients. J. Clin. Psychiatry 2007, 68:1195-1205.
22. StataCorp Stata statistical software: Release 11 2009, StataCorp LP, College Station, TX.
23. Szegedi A., Jansen W.T., van Willigenburg A.P.P., van der Meulen E., Stassen H.H., Thase M.E. Early improvement in the first 2weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J. Clin. Psychiatry 2009, 70:344-353.
24. Rawlings N., Norbury R., Cowen P., Harmer C. A single dose of mirtazapine modulates neural responses to emotional faces in healthy people. Psychopharmacology 2010, 1-10.
25. Tadic A., Helmreich I., Mergl R., Hautzinger M., Kohnen R., Henkel V., Hegerl U. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression. J. Affect. Disord. 2010, 120:86-93.
26. Tugade M.M., Fredrickson B.L. Resilient individuals use positive emotions to bounce back from negative emotional experiences. J Pers Soc Psychol 2004, 86:320-333.
27. Wichers M.C., Barge-Schaapveld D.Q.C.M., Nicolson N.A., Peeters F., de Vries M., Mengelers R., van Os J. Reduced stress-sensitivity or increased reward experience: the psychological mechanism of response to antidepressant medication. Neuropsychopharmacology 2009, 34:923-931.
28. Wichers M.C., Kenis G., Jacobs N., Myin-Germeys I., Schruers K., Mengelers R., Delespaul P., Derom C., Vlietinck R., van Os J. The psychology of psychiatric genetics: evidence that positive emotions in females moderate genetic sensitivity to social stress associated with the BDNF val(66)met polymorphism. J. Abnorm. Psychol. 2008, 117:699-704.
29. Wichers M.C., Myin-Germeys I., Jacobs N., Peeters F., Kenis G., Derom C., Vlietinck R., Delespaul P., Van Os J. Genetic risk of depression and stress-induced negative affect in daily life. Br. J. Psychiatry 2007, 191:218-223.
30. Wichers M.C., Peeters F., Geschwind N., Jacobs N., Simons C.J.P., Derom C., Thiery E., Delespaul P.H., Os J.v. Unveiling patterns of affective responses in daily life may improve outcome prediction in depression: a momentary assessment study. J. Affect. Disord. 2010, 124:191-195.